Datos del Documento


Por favor, use este identificador para citar o enlazar este documento: https://ria.asturias.es/RIA/handle/123456789/676
Registro de Metadatos Completo
Campo Dublin Core Valor Idioma
dc.contributor.authorRomán-García, Pablo-
dc.contributor.authorFernández Martín, José L.-
dc.contributor.authorCannata Andía, Jorge B.-
dc.date.accessioned2010-12-14T09:05:51Z-
dc.date.available2010-12-14T09:05:51Z-
dc.date.issued2010-
dc.identifier.citationExpert opin drug discov.2010eng
dc.identifier.issn1746-045X-
dc.identifier.urihttps://ria.asturias.es/RIA/handle/123456789/676-
dc.description.abstractImportance of the field: The current regulation of parathyroid hormone and the development of parathyroid disorders in chronic kidney disease involve complex mechanisms. Factors such as calcium, phosphorous, calcitriol, vitamin D receptor, calcium-sensing receptor and fibroblast growth factor 23 (FGF23), play a key role in the regulatory process in the pathogenesis of secondary hyperparathyroidism. Areas covered in this review: This review provides an analysis of published results related to the different models and approaches used to study the mechanisms involved in the pathogenesis of secondary hyperparathyroidism. The review includes clinical studies, animal and ex vivo/in vitro models which have been extensively used in this area. What the reader will gain: Readers will have an overview of the main findings and progresses achieved in the knowledge of the parathyroid function combining the results obtained from the different models used to understand the parathyroid gland regulation. Take-home message: Each of the available models used to study the complex system of parathyroid regulation has advantages and limitations; therefore, it is necessary to combine the information obtained from more than one model in order to have a more complete knowledge of the mechanisms involved in parathyroid hormone regulation.eng
dc.description.sponsorshipMarino Santirso Ruiz and Cristina Riesgo for the language review. The papers from our group cited in this review have received support from Fondo de Investigaciones Sanitarias (FIS 00/0008/01, 00/3124, 01/0294, 01/3635, 02/0688, 02/0613, 07/0893), Fundación para el Fomento en Asturias de la Investigación Científica Aplicada y la Tecnología (FICYT PC-SPV01-01, IB05-060), ISCIII-Retic- RD06, REDinREN (16/06) and Fundación Renal Iñigo Alvarez de Toledo. NCL was supported by Fundación Renal Iñigo Alvarez de Toledo, FICYT (IB05-060, 01/3139) and ISCIII-Retic-RD06, REDinREN (16/06) and PRG by Fundación Renal Iñigo Alvarez de Toledo and FICYT.eng
dc.language.isoengeng
dc.publisherInforma Healthcareeng
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/3.0/deed.eseng
dc.subjectIn vivo modelseng
dc.subjectIn vitro modelseng
dc.subjectParathyroid hormoneeng
dc.subjectCalciumeng
dc.subjectPhosphorouseng
dc.subjectFGF-23eng
dc.subjectParathyroid functioneng
dc.subjectSecondary hyperparathyroidismeng
dc.subject.classificationPublicadoeng
dc.titleParathyroid gland regulation: contribution of the IN VIVO and IN VITRO screening models.eng
dc.typearticleeng
Aparece en las colecciones: Open Access DRIVERset
Sanidad

Archivos en este documento:
Fichero Tamaño Formato  
Archivo.pdf165.11 kBAdobe PDFVer/Abrir
Mostrar el registro Básico


Ver estadísticas del documento


Este documento está sujeto a una licencia Creative Commons: Licencia Creative Commons Creative Commons